Cargando…

Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development

Detalles Bibliográficos
Autores principales:	Broen, JCA, Gourh, P, Vonk, M C, Beretta, L, Niederer, F, Rueda, B, Geurts-van Bon, L, Brouwer, C, Hesselstrand, R, Herrick, A, Worthington, J, Hunzelman, N, Denton, C, Fonseca, C, Riemekasten, G, Kiener, H, Scorza, R, Simeon, C P, Fonollosa, V, Carreira, P, Ortego-Centeno, N, Gonzalez-Gay, M A, Airò, P, Coenen, MJH, Mayes, M, Kyburz, D, Arnett, F C, Martin, J, Radstake, TRDJ
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007791/ http://dx.doi.org/10.1186/1479-5876-8-S1-P46

Ejemplares similares

Polymorphisms in the interleukin 4, interleukin 13 and corresponding receptor genes are not associated with Systemic Sclerosis and do not influence gene expression
por: Broen, JCA, et al.
Publicado: (2010)

Skewed X-chromosomal inactivation impacts T regulatory cell function in systemic sclerosis
por: Broen, JCA, et al.
Publicado: (2010)

A rare polymorphism in Toll Like Receptor 2 is associated with systemic sclerosis phenotype and increases production of inflammatory mediators
por: Broen, Jasper CA, et al.
Publicado: (2011)

Biological ageing is a key determinant in systemic sclerosis
por: Shiels, Paul G, et al.
Publicado: (2011)

Identification of novel genetic markers associated with the clinical phenotypes of systemic sclerosis through a genome wide association strategy
por: Gorlova, O, et al.
Publicado: (2010)

A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with Systemic Sclerosis in a large European cohort
por: Bossini-Castillo, L, et al.
Publicado: (2010)

Visfatin/PBEF/Nampt: A New Cardiovascular Target?
por: Peiró, Concepción, et al.
Publicado: (2010)

Nampt/PBEF/visfatin serum levels: a new biomarker for retinal blood vessel occlusions
por: Kaja, Simon, et al.
Publicado: (2015)

Genetics of Systemic Sclerosis: An Update
por: Broen, Jasper C. A., et al.
Publicado: (2011)

Virtual screening, identification and experimental testing of novel inhibitors of PBEF1/Visfatin/NMPRTase for glioma therapy
por: Chandra, Nagasuma, et al.
Publicado: (2011)

Identification of distinct polarized macrophage subsets in inflammatory arthritis
por: Ambarus, C, et al.
Publicado: (2010)

Relationship Between Cerebrospinal Fluid Visfatin (PBEF/Nampt) Levels and Adiposity in Humans
por: Hallschmid, Manfred, et al.
Publicado: (2009)

Common Variants of IL6, LEPR, and PBEF1 Are Associated With Obesity in Indian Children
por: Tabassum, Rubina, et al.
Publicado: (2012)

Triggering of FcGR during dendritic cell maturation leads to a decreased expression of the chemokines DC-CK1, ELC and TARC
por: Radstake, TRDJ, et al.
Publicado: (2004)

Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
por: Gorlova, Olga, et al.
Publicado: (2011)

Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
por: Gorlova, Olga, et al.
Publicado: (2011)

Correction: Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy
por: Gorlova, Olga, et al.
Publicado: (2011)

MicroRNAs underlie plasmacytoid dentritic cell dysfunction in systemic sclerosis
por: Broen, Jasper C, et al.
Publicado: (2012)

Do monocytes use the novel adipocytokine Visfatin/NAMPT/PBEF1 to flip the HIV coreceptor switch?
por: Bergh, Rafael Van den, et al.
Publicado: (2009)

Aberrant Expression of TIMP-2 and PBEF Genes in the Placentae of Cloned Mice Due to Epigenetic Reprogramming Error
por: Kim, Hong Rye, et al.
Publicado: (2016)

Comparison of Enterococcus faecalis Biofilm Removal Efficiency among Bacteriophage PBEF129, Its Endolysin, and Cefotaxime
por: Oh, Hyun Keun, et al.
Publicado: (2021)

KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor
por: Bossini-Castillo, Lara, et al.
Publicado: (2012)

Sustained high expression of Fcγ receptorII (CD32) on dendritic cells (DCs) in patients with rheumatoid arthritis (RA)
por: Radstake, TRDJ, et al.
Publicado: (2002)

Quantification of Double Stranded DNA Breaks and Telomere Length as Proxies for Corneal Damage and Replicative Stress in Human Keratoconus Corneas
por: Wisse, Robert P. L., et al.
Publicado: (2019)

Variations in the PBEF1 gene are associated with body mass index: A population-based study in northern China
por: Rong, Jiesheng, et al.
Publicado: (2015)

Analysis of the association between CD40 and CD40 ligand polymorphisms and systemic sclerosis
por: Teruel, María, et al.
Publicado: (2012)

Strong association of the polymorphisms in PBEF1 and knee OA risk: a two-stage population-based study in China
por: Chu, Minjie, et al.
Publicado: (2016)

Toll-like receptor 4 polymorphism influences susceptibility to but not severity and outcome of rheumatoid arthritis
por: Radstake, TRDJ, et al.
Publicado: (2004)

The Systemic Lupus Erythematosus IRF5 Risk Haplotype Is Associated with Systemic Sclerosis
por: Carmona, F. David, et al.
Publicado: (2013)

Unique Toll-Like Receptor 4 Activation by NAMPT/PBEF Induces NFκB Signaling and Inflammatory Lung Injury
por: Camp, Sara M., et al.
Publicado: (2015)

The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes
por: Radstake, Timothy R. D. J., et al.
Publicado: (2009)

Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans
por: Friebe, D., et al.
Publicado: (2011)

A multicenter study confirms CD226 gene association with systemic sclerosis-related pulmonary fibrosis
por: Bossini-Castillo, Lara, et al.
Publicado: (2012)

The Cytokine Nicotinamide Phosphoribosyltransferase (eNAMPT; PBEF; Visfatin) Acts as a Natural Antagonist of C-C Chemokine Receptor Type 5 (CCR5)
por: Torretta, Simone, et al.
Publicado: (2020)

Increased FcγRII and III expression in synovium and on monocyte derived macrophages of RA-patients results in altered function after immune complex stimulation
por: Blom, AB, et al.
Publicado: (2002)

Expression of Toll-like receptor (TLR) 2, TLR3, TLR4 and TLR7 is increased in rheumatoid arthritis synovium and regulates cytokine production by dendritic cells upon stimulation of TLR specific pathways
por: Roelofs, MF, et al.
Publicado: (2005)

Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1β, and Anemia
por: Neubauer, Katarzyna, et al.
Publicado: (2015)

Proteomic analysis of Systemic Sclerosis serum identifies the toll-like receptor agonists S100A8/A9 as a novel possible pathogenic marker
por: van Bon, L, et al.
Publicado: (2010)

Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations
por: Gourh, Pravitt, et al.
Publicado: (2009)

Unwarranted variation of coronary stent choice in The Netherlands
por: Bekkers, S.C.A.M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fbo1fhcij3snhmcnn8hj0smncq